NO310023B1 - Benzylpiperidinderivater, farmasöytiske preparater som inneholder dem, og anvendelse av derivatene til fremstilling av legemidler - Google Patents

Benzylpiperidinderivater, farmasöytiske preparater som inneholder dem, og anvendelse av derivatene til fremstilling av legemidler Download PDF

Info

Publication number
NO310023B1
NO310023B1 NO954349A NO954349A NO310023B1 NO 310023 B1 NO310023 B1 NO 310023B1 NO 954349 A NO954349 A NO 954349A NO 954349 A NO954349 A NO 954349A NO 310023 B1 NO310023 B1 NO 310023B1
Authority
NO
Norway
Prior art keywords
acid
formula
benzyl
compounds
derivatives
Prior art date
Application number
NO954349A
Other languages
English (en)
Norwegian (no)
Other versions
NO954349D0 (no
NO954349L (no
Inventor
Helmut Pruecher
Rudolf Gottschlich
Joachim Leibrock
Harry Schwartz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4438810A external-priority patent/DE4438810A1/de
Priority claimed from DE1995126269 external-priority patent/DE19526269A1/de
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO954349D0 publication Critical patent/NO954349D0/no
Publication of NO954349L publication Critical patent/NO954349L/no
Publication of NO310023B1 publication Critical patent/NO310023B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO954349A 1994-10-31 1995-10-30 Benzylpiperidinderivater, farmasöytiske preparater som inneholder dem, og anvendelse av derivatene til fremstilling av legemidler NO310023B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4438810A DE4438810A1 (de) 1994-10-31 1994-10-31 Benzylpiperidinderivate
DE1995126269 DE19526269A1 (de) 1995-07-19 1995-07-19 Benzylpiperidinderivate

Publications (3)

Publication Number Publication Date
NO954349D0 NO954349D0 (no) 1995-10-30
NO954349L NO954349L (no) 1996-05-02
NO310023B1 true NO310023B1 (no) 2001-05-07

Family

ID=25941544

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954349A NO310023B1 (no) 1994-10-31 1995-10-30 Benzylpiperidinderivater, farmasöytiske preparater som inneholder dem, og anvendelse av derivatene til fremstilling av legemidler

Country Status (23)

Country Link
US (1) US5698553A (pl)
EP (1) EP0709384B1 (pl)
JP (1) JPH08225569A (pl)
KR (1) KR100388593B1 (pl)
CN (1) CN1064358C (pl)
AT (1) ATE174915T1 (pl)
AU (1) AU703487B2 (pl)
BR (1) BR9505008A (pl)
CA (1) CA2161618A1 (pl)
CZ (1) CZ288039B6 (pl)
DE (1) DE59504622D1 (pl)
DK (1) DK0709384T3 (pl)
ES (1) ES2128629T3 (pl)
FI (1) FI955184A7 (pl)
GR (1) GR3029771T3 (pl)
HU (1) HUT76068A (pl)
NO (1) NO310023B1 (pl)
PL (1) PL182210B1 (pl)
RU (1) RU2160259C2 (pl)
SK (1) SK282476B6 (pl)
TR (1) TR199501331A2 (pl)
TW (1) TW394770B (pl)
UA (1) UA41927C2 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE174915T1 (de) * 1994-10-31 1999-01-15 Merck Patent Gmbh Benzylpiperidinderivate mit hoher affinität zu bindungsstellen von aminosäure-rezeptoren
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
DE19643790A1 (de) * 1996-10-30 1998-05-07 Merck Patent Gmbh Benzoxazol-Derivat
US6110935A (en) * 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses
CA2282390A1 (en) * 1997-04-17 1998-10-22 Yukio Fujisawa Thermogenic composition and benzazepine thermogenics
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
DE19812331A1 (de) * 1998-03-20 1999-09-23 Merck Patent Gmbh Piperidinderivate
US6448257B1 (en) 1998-05-22 2002-09-10 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6867209B1 (en) 1998-05-22 2005-03-15 Scios, Inc. Indole-type derivatives as inhibitors of p38 kinase
US6340685B1 (en) 1998-05-22 2002-01-22 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6589954B1 (en) 1998-05-22 2003-07-08 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
KR100605140B1 (ko) * 1998-05-22 2006-07-28 싸이오스 인크 심장병 및 다른 질병을 치료하기 위한 헤테로 고리 화합물및 그 치료 방법
US6130235A (en) * 1998-05-22 2000-10-10 Scios Inc. Compounds and methods to treat cardiac failure and other disorders
PE20000728A1 (es) 1998-06-26 2000-08-21 Cocensys Inc Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda
IL146309A (en) 1999-05-21 2008-03-20 Scios Inc Derivatives of the indole type and pharmaceutical preparations containing them as inhibitors of kinase p38
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
DE10120159A1 (de) * 2001-04-25 2002-10-31 Merck Patent Gmbh NMDA-Antagonisten und NMDA-Agonisten zur Behandlung von Suchterkrankungen
JPWO2003035641A1 (ja) * 2001-10-22 2005-02-10 塩野義製薬株式会社 新規カルバモイルピロリドン誘導体
DE10210779A1 (de) * 2002-03-12 2003-10-09 Merck Patent Gmbh Cyclische Amide
DE10217006A1 (de) 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
RU2323456C2 (ru) * 2002-06-11 2008-04-27 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Способ и система для геологических исследований дна моря с использованием измерения вертикального электрического поля
ITTO20040124A1 (it) * 2004-03-01 2004-06-01 Medestea Internaz Srl Nuovi impieghi in terapia di derivati di n-piperidina particolarmente per il trattamento di patologie neurodegenerative
EP1736474A4 (en) * 2004-04-07 2010-04-21 Kyowa Hakko Kirin Co Ltd piperidine
AP2502A (en) * 2007-01-03 2012-10-23 Servier Lab 3-substituted-[1,2,3]-benzotriazinone compound forenhancing glutamatergic synaptic responses
DE102007047737A1 (de) * 2007-10-05 2009-04-30 Merck Patent Gmbh Piperidin- und Piperazinderivate
TWI410420B (zh) * 2008-02-05 2013-10-01 Dainippon Sumitomo Pharma Co 苄基哌啶化合物
US8778970B2 (en) 2009-08-04 2014-07-15 Dainippon Sumitomo Pharma Co., Ltd Benzyl piperidine compound
DE102009049211A1 (de) 2009-10-13 2011-04-28 Merck Patent Gmbh Sulfoxide
TWI507441B (zh) * 2010-12-21 2015-11-11 Sumitomo Chemical Co 高分子化合物及使用該化合物之發光元件
KR101799137B1 (ko) * 2010-12-21 2017-11-17 스미또모 가가꾸 가부시키가이샤 고분자 화합물 및 그것을 이용한 발광 소자
KR102277538B1 (ko) * 2015-06-08 2021-07-14 주식회사 대웅제약 신규한 헤테로 고리 화합물, 이의 제조 방법 및 이를 포함하는 약학적 조성물
AR110963A1 (es) 2017-02-07 2019-05-22 Dae Woong Pharma Compuestos heterocíclicos, su método de preparación y composición farmacéutica que los comprende

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.
JPS57142972A (en) * 1981-02-27 1982-09-03 Otsuka Pharmaceut Co Ltd Carbostyril derivative
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
JPH0753913B2 (ja) * 1990-11-14 1995-06-07 新日本製鐵株式会社 有機複合めっき鋼板の製造方法
US5338361A (en) * 1991-11-04 1994-08-16 Measurex Corporation Multiple coat measurement and control apparatus and method
FR2688504B1 (fr) * 1992-03-13 1995-05-05 Synthelabo Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
ATE174915T1 (de) * 1994-10-31 1999-01-15 Merck Patent Gmbh Benzylpiperidinderivate mit hoher affinität zu bindungsstellen von aminosäure-rezeptoren

Also Published As

Publication number Publication date
JPH08225569A (ja) 1996-09-03
KR100388593B1 (ko) 2003-09-19
US5698553A (en) 1997-12-16
FI955184L (fi) 1996-05-01
CZ288039B6 (cs) 2001-04-11
DE59504622D1 (de) 1999-02-04
EP0709384A1 (de) 1996-05-01
BR9505008A (pt) 1997-10-14
GR3029771T3 (en) 1999-06-30
CN1064358C (zh) 2001-04-11
FI955184A0 (fi) 1995-10-30
TW394770B (en) 2000-06-21
NO954349D0 (no) 1995-10-30
NO954349L (no) 1996-05-02
PL311185A1 (en) 1996-05-13
AU3443595A (en) 1996-05-09
DK0709384T3 (da) 1999-08-23
AU703487B2 (en) 1999-03-25
EP0709384B1 (de) 1998-12-23
HUT76068A (en) 1997-06-30
SK282476B6 (sk) 2002-02-05
SK135595A3 (en) 1996-06-05
ATE174915T1 (de) 1999-01-15
PL182210B1 (pl) 2001-11-30
TR199501331A2 (tr) 1996-06-21
CZ281695A3 (en) 1996-05-15
CN1128762A (zh) 1996-08-14
KR960014119A (ko) 1996-05-22
RU2160259C2 (ru) 2000-12-10
UA41927C2 (uk) 2001-10-15
HU9503101D0 (en) 1995-12-28
CA2161618A1 (en) 1996-05-01
ES2128629T3 (es) 1999-05-16
FI955184A7 (fi) 1996-05-01

Similar Documents

Publication Publication Date Title
NO310023B1 (no) Benzylpiperidinderivater, farmasöytiske preparater som inneholder dem, og anvendelse av derivatene til fremstilling av legemidler
RU2132848C1 (ru) Производные пиперидина и пиперазина, способ их получения, содержащие их фармацевтические композиции и способ их получения
EP0300272B1 (de) Oxazolidinone
RU2194048C2 (ru) Производные пиперазина, способ их получения и фармацевтическая композиция
JP4451565B2 (ja) ピペリジン誘導体
CZ285369B6 (cs) Derivát 3-indolylpiperidinu, způsob jeho přípravy, jeho použití pro přípravu farmaceutického prostředku a farmaceutický prostředek, který ho obsahuje
NO821616L (no) 1-substituert-spiro(piperidin-oksobenzoksazin)er og fremgangsmaate for deres fremstilling
TW401417B (en) 4-Aryloxy- and 4-arylthiopiperidine derivatives
NO313415B1 (no) Oksazolidiner, fremgangsmåte for fremstilling derav, farmasöytiske preparater, fremgangsmåte for fremstilling derav,forbindelsene 5-HT2A-antagonister, samt anvendelse avforbindelsene til fremstilling av legemidler
US20040014972A1 (en) Arylpiperazine derivatives and their use as psychotropic agents
NO309038B1 (no) Fenylindolforbindelser
CZ231898A3 (cs) Derivát 1-(pyrazol-3-ylethyl)-4-(indol-3-yl)piperidinu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
HU194555B (en) Process for production of new derivatives of indole and medical preparatives containing them
NZ297312A (en) 1-[2-phenyl-4-(4-(3-hydroxythien-2-yl)piperidino)butanoyl]azepane derivatives
HU195652B (en) Process for preparing pyridine derivatives and pharmaceutical compositions containing such compounds as active ingredients
CZ20003404A3 (cs) Derivát l-(3-heteroarylpropyl-nebo-prop-2-enyl)- 4-benzylpiperidinu jakožto antagonist NMDA receptoru, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
AU2005217043B2 (en) Piperidine derivatives
HU196994B (en) Process for producing pyridine derivatives and pharmaceuticals comprising same
MXPA00009090A (en) 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees